Techno Medica Co., Ltd. (TYO:6678)

Japan · Delayed Price · Currency is JPY

1,947.00

-6.00 (-0.31%)

Jun 24, 2026, 3:24 PM JST

6.98% (1Y)

Market Cap	13.61B +9.4%
Revenue (ttm)	11.24B +13.4%
Net Income	1.07B +6.6%
EPS	155.14 +7.0%
Shares Out	6.97M
PE Ratio	12.59
Forward PE	n/a
Dividend	68.00 (3.50%)
Ex-Dividend Date	Mar 30, 2026

Volume	3,500
Open	1,953.00
Previous Close	1,953.00
Day's Range	1,944.00 - 1,957.00
52-Week Range	1,815.00 - 2,787.00
Beta	0.24
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Techno Medica

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers automated tube selecting and labeling systems, RFID process control system, blood and urine collection support, and pre-analytical instrument. It also provides consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1987

Employees 244

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 6678

Full Company Profile

Financial Performance

In fiscal year 2026, Techno Medica's revenue was 11.24 billion, an increase of 13.44% compared to the previous year's 9.91 billion. Earnings were 1.07 billion, an increase of 6.57%.

Financial Statements